The R-H polymorphism of FCγ receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter
Hilde M. Dijstelbloem PhD
University Hospital Groningen, Groningen, The Netherlands
Search for more papers by this authorBouke G. Hepkema PhD
University Hospital Groningen, Groningen, The Netherlands
Search for more papers by this authorCees G. M. Kallenberg MD, PhD
University Hospital Groningen, Groningen, The Netherlands
Search for more papers by this authorMichiel W. Van Der Linden MD, PhD
Leiden University Medical Center, Leiden, The Netherlands
Search for more papers by this authorVivian Keijsers
Leiden University Medical Center, Leiden, The Netherlands
Search for more papers by this authorTom W. J. Huizinga MD, PhD
Leiden University Medical Center, Leiden, The Netherlands
Search for more papers by this authorMarc D. Jansen
University Medical Center Utrecht, Utrecht, The Netherlands
Search for more papers by this authorJan G. J. van de Winkel PhD
University Medical Center Utrecht, Utrecht, The Netherlands
Search for more papers by this authorHilde M. Dijstelbloem PhD
University Hospital Groningen, Groningen, The Netherlands
Search for more papers by this authorBouke G. Hepkema PhD
University Hospital Groningen, Groningen, The Netherlands
Search for more papers by this authorCees G. M. Kallenberg MD, PhD
University Hospital Groningen, Groningen, The Netherlands
Search for more papers by this authorMichiel W. Van Der Linden MD, PhD
Leiden University Medical Center, Leiden, The Netherlands
Search for more papers by this authorVivian Keijsers
Leiden University Medical Center, Leiden, The Netherlands
Search for more papers by this authorTom W. J. Huizinga MD, PhD
Leiden University Medical Center, Leiden, The Netherlands
Search for more papers by this authorMarc D. Jansen
University Medical Center Utrecht, Utrecht, The Netherlands
Search for more papers by this authorJan G. J. van de Winkel PhD
University Medical Center Utrecht, Utrecht, The Netherlands
Search for more papers by this author
REFERENCES
- 1 Tsao BP. Lupus susceptibility genes on human chromosome 1. Int Rev Immunol 2000; 19: 319–34.
- 2 Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A 1998; 95: 14869–74.
- 3 D'Alfonso S, Rampi M, Bocchio D, Colombo G, Scorza-Smeraldi R, Momigliano-Richardi P. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum 2000; 43: 120–8.
- 4 Van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993; 14: 215–21.
- 5 Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46: 120–8.
- 6 Van der Pol W-L, van de Winkel JGJ. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 1998; 48: 222–32.
- 7 Dijstelbloem HM, Bijl M, Fijnheer R, Scheepers RH, Oost WW, Jansen MD, et al. Fcγ receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis Rheum 2000; 43: 2793–800.
- 8 Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WER, et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997; 24: 2314–7.
- 9 Rood MJ, Keijsers V, van der Linden MW, Tong TQT, Borggreve SE, Verweij CL, et al. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann Rheum Dis 1999; 58: 85–9.
- 10 Kube D, Platzer C, von Knethen A, Straub H, Bohlen H, Hafner M, et al. Isolation of the human interleukin 10 promoter: characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 1995; 7: 1–7.
- 11 Van der Pol W-L, Huizinga TWJ, Vidarsson G, van der Linden MW, Jansen MD, Keijsers V, et al. Relevance of FcγR and IL-10 polymorphisms for meningococcal disease. In: W-L van der Pol. Fc receptor-mediated immunity against S. pneumoniae and N. meningitidis. Wageningen: Ponsen & Looijen; 2000. p. 143–155.
- 12 Van der Linden MW, Westendorp RGJ, Sturk A, Bergman W, Huizinga TW. High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneaous lupus erythematosus. J Investig Med 2000; 48: 327–34.
- 13 Crawley E, Woo P, Isenberg DA. Single nucleotide polymorphic haplotypes of the interleukin-10 5′ flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2017–8.
- 14 Westendorp RGJ, Langermans JAM, Huizinga TWJ, Elouali AH, Verwij CL, Boomsma DI, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170–3.
- 15 Llorente L, Richaud-Patin Y, Couderc J, Alarcon-Segovia D, Ruiz-Soto R, Alcocer-Castillejos N, et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1429–35.
- 16 Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997; 49: 635–9.
